Dr. James Buxbaum, MD
Claim this profileLos Angeles County Hospital
Studies Pancreatitis
Studies Acute Pancreatitis
13 reported clinical trials
17 drugs studied
Affiliated Hospitals
Clinical Trials James Buxbaum, MD is currently running
Antibiotics
for Cholangitis
Endoscopic retrograde cholangiopancreatography (ERCP) is an endoscopic procedure used to treat bile duct stones, obstructive jaundice, biliary leaks, and a variety of other conditions. There is active debate whether antibiotics should be given prophylactically for ERCP outside of high risk indications including primary sclerosing cholangitis. In part this is due to a lack of appropriately powered clinical trials with adequate follow up. The aim will be to assess whether prophylactic antibiotics decrease the rate of post ERCP cholangitis as defined by the Revised Tokyo Criterion.
Recruiting3 awards Phase 4
Sphincterotomy
for Acute Recurrent Pancreatitis
The purpose of this study is to determine if a procedure called Endoscopic Retrograde CholangioPancreatography (ERCP) with sphincterotomy reduces the risk of pancreatitis or the number of recurrent pancreatitis episodes in patients with pancreas divisum. ERCP with sphincterotomy is a procedure where doctors used a combination of x-rays and an endoscope (a long flexible lighted tube) to find the opening of the duct where fluid drains out of the pancreas. People who have been diagnosed with pancreas divisum, have had at least two episodes of pancreatitis, and are candidates for the ERCP with sphincterotomy procedure may be eligible to participate. Participants will be will be randomly assigned to either have the ERCP with sphincterotomy procedure, or to have a "sham" procedure. Participants will have follow up visits 30 days after the procedure, 6 months after the procedure, and continuing every 6 months until a maximum follow-up period of 48 months.
Recruiting0 awards N/A7 criteria
More about James Buxbaum, MD
Clinical Trial Related7 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments James Buxbaum, MD has experience with
- Initial Therapy With Papillary Balloon Dilation
- Initial Therapy With Intraductal Lithotripsy
- Levofloxacin
- Ceftriaxone
- EUS Enhanced With Contrast To Evaluate Pancreas
- EUS With Fiducial
Breakdown of trials James Buxbaum, MD has run
Pancreatitis
Acute Pancreatitis
Colorectal Cancer
Gallstone Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James Buxbaum, MD specialize in?
James Buxbaum, MD focuses on Pancreatitis and Acute Pancreatitis. In particular, much of their work with Pancreatitis has involved treating patients, or patients who are undergoing treatment.
Is James Buxbaum, MD currently recruiting for clinical trials?
Yes, James Buxbaum, MD is currently recruiting for 7 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that James Buxbaum, MD has studied deeply?
Yes, James Buxbaum, MD has studied treatments such as Initial therapy with papillary balloon dilation, Initial therapy with intraductal lithotripsy, Levofloxacin.
What is the best way to schedule an appointment with James Buxbaum, MD?
Apply for one of the trials that James Buxbaum, MD is conducting.
What is the office address of James Buxbaum, MD?
The office of James Buxbaum, MD is located at: Los Angeles County Hospital, Los Angeles, California 90033 United States. This is the address for their practice at the Los Angeles County Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.